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Abstract 
 
Purpose:  There is some debate regarding whether artificial reproductive 
technology (ART) constitutes an independent risk factor for retinopathy of 
prematurity (ROP). We wanted to assess the prevalence of ART in multiple birth 
infants seen for ROP screening and whether or not ROP was identified or 
treated, in order to evaluate whether ART contributes a risk factor for ROP 
independent of the generation of multiple births. 
Methods:  A retrospective audit was performed of all multiple birth babies 
admitted to a tertiary Neonatal unit who met the UK ROP screening criteria (<32 
weeks gestational age (GA) and/or <1501g birth weight (BW)).   
Results:  205 babies met our criteria of which 87.3% were twins.  39.5% were 
born following ART. 30.5% of the non-ART group developed ROP versus 34% of 
the ART group (P=0.837).  Stage 3 ROP developed in 5.1% non-ART babies and 
6% ART babies. 8.5% non-ART babies and 10% ART babies required treatment 
for ROP.  Logistic regression demonstrated that ART was not independently 
associated with development of ROP. 
Conclusions:  ART multiple birth babies make up a considerable proportion of 
the ROP screening burden and their number is likely to increase as ART is 
increasingly available and utilised. We found no significant difference between 
the numbers of babies developing ROP in the ART versus non-ART groups, but 
the numbers are small. The estimated odds of developing ROP is slightly higher 
in the ART babies so our data do not rule out a possible association. 
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Is artificial reproductive technology a risk factor for retinopathy of 
prematurity independent of the generation of multiple births? 
Barker L, Husain S, Bunce C, Adams G 
 
Introduction 
 
Artificial reproductive technology (ART) has been responsible for an increased 
rate of both premature and multiple births in the UK since the birth of the first in 
vitro fertilisation (IVF) baby in 1978.  ART increases the risk of preterm birth both 
independently and by increasing the risk of multiple births whereby babies are 
more likely to be born earlier and smaller (1,2,3,4). In recognition of the 
increased morbidity and mortality associated with these risks the UK’s Human 
Fertility and Embryology Association (HFEA) and British Fertility Society (BFS) 
introduced guidance in 2008 encouraging the use of elective single embryo 
transfer (eSET) in mothers at greatest risk of multiple birth (5).  In older mothers, 
where the risk is lower, it was recommended that no more than two embryos 
should be transferred.  These recommendations have been shown elsewhere in 
Europe to maintain the live birth rates following IVF but significantly lower the 
rate of multiple births, particularly of higher plurality (6).  In 2015, the HFEA 
published a report detailing a significant reduction in the rate of multiple birth 
pregnancies in the UK since the publication in 2008, reduced from 1 in 4 in 2008 
to 1 in 6 in 2013 (7).  During this time period, the overall rate of successful 
pregnancies actually increased slightly from 30% to 34% and eSET use had 
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markedly increased from less than 5% patients to 29%.  This reduction in 
iatrogenic multiple births is significant when one considers the increased rate of 
morbidity in babies born from multiple pregnancies. 
 
All babies who are born significantly premature are at risk of retinopathy of 
prematurity (ROP).  The risk increases in multiple births due to the increased rate 
of lower gestational age and birth weight. It is unclear whether ART, and IVF in 
particular, represents an independent risk factor for neonatal morbidity, in 
particular, ROP.  Studies have demonstrated a positive, negative or neutral effect 
of ART on neonatal outcomes (8,9,10).  Whilst it has been suggested that the 
process and results of IVF may represent an independent risk factor for ROP, 
others have concluded that it is simply the increased rates of prematurity and low 
birth weight which generate the higher rates of ROP in children born following 
ART (11,12). 
 
In 1996, McKibbin & Dabbs noted that of the babies born following ART at St 
James’s University Hospital, Leeds, 59 (20.3%) met the criteria for retinopathy of 
prematurity (ROP) screening and 56 (94.9%) of those were multiple births 
(33.9% twins, 66.1% triplets) (13).  Of these 56 babies, 22.7% developed ROP 
and 4.5% required treatment.  Funnell & Dabbs repeated the audit in 2007, prior 
to the change in HFEA guidance, and found that only 4.2% (11/265) of those who 
met the screening criteria were born following ART, comprising 3 singletons and 
4 sets of twins (14).  None of these babies developed ROP.  This significant 
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reduction in the proportion of ART multiple births seen for ROP screening, can be 
at least partly attributed to technological advances in fertility treatment allowing 
fewer embryos to be transferred during treatment without compromising the 
success rates.  It remained the norm however, at this time point, to transfer more 
than one embryo in order to maximise the chance of a successful implantation 
and subsequent pregnancy. 
 
The purpose of this study was to assess the situation regarding multiples in our 
ROP screening population, in particular, the prevalence of ART in multiple birth 
infants seen for ROP screening and whether or not ROP was identified or 
treated, in order to evaluate whether ART contributes a risk factor for ROP 
independent of the generation of multiple births. 
 
Methods 
 
A retrospective audit was performed in the tertiary Neonatal Unit of Homerton 
University Hospital NHS Foundation Trust (HUH). All live births at HUH between 
January 2007 and December 2011 inclusive who met the RCOphth screening 
criteria (babies born <32 weeks and/or < 1501g) were identified using a neonatal 
database housed by the BadgerNet Platform (http://www.clevermed.com). This 
database, used by the majority of neonatal units in the UK, captures a number of 
parameters including gestational age at birth (GA) and birth weight (BW).  The 
audit was performed with the permission of HUH’s Clinical Audit Department. 
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Data from multiple births who met the ROP screening criteria were extracted 
from hospital clinical notes and databases.  Data collected included maternal age 
and self-reported ethnicity, the baby’s GA, BW, and presence of major congenital 
anomalies, mode of conception (spontaneous or assisted), type of ART, plurality, 
and ROP screening outcome. 
 
Study characteristics were summarised by spontaneous conception versus ART 
using means and standard deviations for continuous data and numbers with 
proportions for categorical data.  Group differences were assessed using Fisher’s 
exact test for categorical variables and t-tests for continuous variables.  Logistic 
regression was used to identify whether the odds of having ROP were associated 
with ART. 
 
Results 
 
There were 24,229 live births at HUH in the 5-year audit period.  Of these, 1015 
(4.2%) were multiple births. In total, 1272 (5.2%) babies met the ROP screening 
criteria; 205 (16.1%) of these were multiple births.  20.2% multiple birth babies 
met the screening criteria versus 4.6% singleton babies.  Data completeness was 
100%.   
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Focussing on the multiple births babies who met the screening criteria, the 
average maternal age was 31 years (SD 6.7 years; range 18-50).  Self-reported 
maternal ethnicity was White British/Irish in 83 (41%), Black/Black British in 41 
(20%), Asian/Asian British in 41 (20%), Other in 27 (12.7%); in 13 (6.3%) no 
ethnicity was recorded. 
 
The mean gestational age of the babies was 28 weeks (range 22-35 weeks) and 
mean birth weight was 1063g (range 338-1845g). Of the 205 multiple births, 106 
(51.7%) were male, 179 (87.3%) were twins, 21 (10.2 %) were triplets and 5 
(2.4%) were quintuplets.  
 
Eighty-one babies (39.5%) were born following ART with the remainder being 
spontaneous conceptions.  Of those born following ART, 69 (86.3%) were born 
following IVF (3 of these also used a donor egg), 2 (2.5%) following 
intracytoplasmic sperm injection (ICSI) and 9 (11.1%) using Clomifene.  The 
mean gestational age in both the assisted and spontaneous conception groups 
was the same at 28.3 weeks and there was no significant difference between the 
birth weights (P = 0.28).  The characteristics of both groups can be seen in table 
1. 
 
Twenty-one babies (10.3%) died before ROP screening commenced.  One 
hundred and eight (53%) of the babies were screened at HUH, 1 was screened 
elsewhere before transfer in to the unit for medical reasons (included in the study 
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as full ROP details were available), 1 baby failed to attend their screening 
appointment twice and the remainder were transferred elsewhere prior to 
screening.  There was no difference between babies screened and not screened 
in relation to maternal age or ethnicity.  Of those babies screened for ROP at 
HUH, 35 were found to have ROP of any stage; 30.5% of the spontaneous 
conception babies and 34% of the ART babies (see table 2).  This difference was 
not statistically significant (P=0.837).  
 
Stage 3 ROP developed in 6% ART babies and 5.1% of the spontaneously 
conceived babies. In total, 10 babies required treatment for ROP; 5 (8.5%) of the 
spontaneously conceived group and 5 (10%) of the ART group.  The proportions 
of babies in each stage did not differ between ART and non ART babies 
(P=0.93). 
 
Using logistic regression, we found that BW and GA were significantly associated 
with the development of any ROP whereas ART was not (Table 3). 
 
Discussion 
 
Our results show that 4.2% live births at our centre during this study period were 
multiple births and infants born from a multiple pregnancy constituted 16.1% of 
the ROP screening population.  ART was the mode of conception in 39% of 
multiple births eligible for ROP screening and multiple birth babies born as a 
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result of ART made up 6.3% of our total screening population.  Although we 
would expect to see a continuing reduction in the number of multiple births in the 
UK given the 2015 HFEA report, this group remains relatively sizeable and may 
continue to increase as the availability of ART increases and its use becomes 
more commonplace due to the trend of women leaving motherhood until later in 
life (7). 
 
Over the five years covered by the audit, the rate of multiple pregnancies in 
England and Wales increased slightly, from 15.3 per 1000 births in 2007 to 16.1 
in 2011 (15). Higher order multiples (triplets and above) have remained static 
over this period (1.4% all multiple births in 2006 and 1.5% in 2011) (16,17).  
Elsewhere in the world, a downward trend in higher order multiples has been 
observed.  Bassil et al (2012) found the rate of triplet birth significantly decreased 
between 2003 and 2008 in Canada whereas the number of pre-term twins 
increased (18).  Due to advances in healthcare and technology, neonatal 
outcomes improved over this time period in these Canadian infants, including a 
reduction in the rate of severe ROP.   
 
We found the rates of higher order multiple births to be lower than in the 1996 
study by McKibben and Dabbs study but higher than that of the follow-up study 
by Funnell and Dabbs (13,14).  We had one set of quintuplets following fertility 
treatment in another country, but the rate of triplets following ART was 5% 
compared to 66.1% in the study by McKibben and Dabbs and 0% in Funnell and 
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Dabbs (13,14). It is worth noting however, that the latter study was conducted 
over a 40-month period versus our 60-month study.  It is perhaps of concern that 
the rate of higher plurality births might be increasing again although we found 
that several of our mothers, particularly when the maternal age was significantly 
higher than average, went abroad for their IVF treatment to countries where the 
regulation of fertility treatment is less strict than that in the UK, returning to the 
UK to deliver their babies. 
 
We found no significant difference between the numbers of babies developing 
ROP in the ART versus non-ART groups, but the numbers are small. The 
estimated odds of developing ROP is slightly higher in the ART babies with an 
odds ratio of 1.17 (0.52, 2.63) and an adjusted (for BW) OR of 1.23 (0.497, 3.04) 
so our data do not rule out a possible association.  Also, 74 of the 205 babies 
who met the screening criteria were transferred elsewhere prior to the start of 
their screening.  Although it is likely that they would have been transferred back 
to the unit for treatment should this have been necessary due to the referral 
pathway in the region, we cannot comment on the presence or severity of ROP in 
this group.  
 
There is dispute in the literature regarding the role of ART as a risk factor for 
ROP.  Watts & Adams (2000) reported a disproportionately high rate of ART in 
their ROP treated population (28.6%) compared to their ROP screened 
population (11.7%)(11). Shah et al (2011) reported that, once corrected for 
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confounding variables, the mode of conception had no detectable effect on 
composite neonatal outcomes including advanced ROP (19).  It is well 
established that the most significant risk factors for development of ROP are low 
BW and GA and there appears to be a higher rate of early pre-term delivery (GA 
< 32 weeks) and low BW in the ART population which may account for the higher 
rates of ROP seen (3,12,20).  Our audit found no difference between BW and GA 
of babies in the ART and spontaneous conception groups, meaning we cannot 
exclude ART as an additional risk factor although it is noteworthy that we did not 
collect data, and therefore cannot comment, on other risk factors for ROP such 
as neonatal co-morbidity and poor weight gain. 
 
Another factor, which may be of significance, is the proportion of mono- and 
dizygotic twins within the study population.  Given the technique of IVF, it is 
obvious that most twins born following ART will be dizygotic however a small 
proportion (<2%) are monozygotic and Vitthala et al (2009) have identified a 
significantly higher rate of monozygotic twins following ART than spontaneous 
conception in their meta-analysis (7,21).  As the majority of monozygotic twins 
are monochorionic, with a known increased rate of perinatal morbidity and 
mortality, it is possible that this plays a significant role in the development of any 
ROP by increasing the vulnerability of the developing foetuses (22).  The 
identical genetics of monozygotic twins may also be of relevance given the 
evidence to suggest a genetic influence in the development of ROP (23).  We did 
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not gather data on the zygocity of our infants and suggest that further work is 
needed in this area.  
 
In 2011, a Canadian study identified an “epidemic of multiple gestations” due to 
the practice of multiple embryo transfer in IVF and found that 17% NICU 
admissions over a 2-year period were multiple birth infants born after ART (24).  
Extrapolating the figures, they identified what was described as the “cost of 
irresponsibility” and concluded that eSET could prevent 30-40 neonatal deaths 
and between 13-19 retinal procedures per year without jeopardising the success 
rate of IVF treatment.  In Sweden, eSET has been the norm since 2000.  Kallen 
et al (2010) reported on the IVF outcome trends over a 5-year period in Sweden 
and found, on a background of a stable IVF success rate, not only a decrease in 
multiple birth rate to around 5%, but also significant improvements in the health 
outcomes of both mother and child (6).  Boulet et al (2008) noted no increase in 
neonatal morbidity in post ART twins compared to spontaneously conceived 
twins in the US; however, they did conclude that the higher risks associated with 
multiple births could be avoided by the promotion of singleton gestation in ART 
(25). 
 
Multiple births made up 16.1% of our ROP screening load.  This figure is similar 
to those reported from Italy (13.4%) and the US (17%)(26,28). However, it 
represents a smaller screening burden compared to other international studies 
(see table 4).  Whilst it is possible that this is due to differences in fertility 
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treatment guidelines and availability, it should be noted that the percentage of 
multiple birth infants born following ART is similar across the international 
literature (see table 4). 
 
Since the launch of the HFEA’s “One at a time” campaign in 2009, increasing use 
of eSET in UK IVF clinics has seen the multiple birth rate fall from 27% to close 
to 16% whilst the overall successful pregnancy rate increases from 30% to 
34%(7).  This has caused a reduction in higher order multiple births and a 
subsequent reduction in the ROP screening burden overall.  In February 2013, 
NICE guidelines were published echoing the recommendation to use eSET in 
healthy, younger mothers where the risk of multiple birth following multiple 
embryo transfer remains high and the 2015 HFEA report results demonstrate the 
successful collaboration between the HFEA, fertility clinics and practitioners, all 
keen to reduce the rate of iatrogenic multiple births.  Due to a legal challenge 
however, since January 2014, UK fertility clinics have been no longer subject to a 
condition on their licence that they maintain their multiple birth rate below a 
centrally dictated target.  This raises the possibility that we might expect to see 
the multiple birth and higher plurality rates increasing once again as clinics 
transfer more embryos in order to achieve higher success rates in the 
competitive world of fertility medicine.  As such, paediatric ophthalmologists 
might expect an increase in both their screening workload and the numbers of 
babies requiring ROP treatment over the months and years to come. 
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 Spontaneous 
conception 
ART 
Total, number 124 81 
Gestational age (weeks), 
mean (SD) 
28.3 (2.5) 28.3 (3.0) 
Birth weight (grams), 
mean (SD) 
1043 (290) 1093 (360) 
Maternal age (years), 
mean (SD) 
28.9 (5.4) 34.5 (7.2) 
 
 
Ethnicity, 
number 
(%) 
White/British 44 (35.5%) 39 (48.1%) 
Asian/Asian 
British 
28 (22.6%) 13 (16.1%) 
Black/Black 
British 
26 (21.0%) 15 (18.5%) 
Mixed 3 (2.4%) 1 (1.2%) 
Other 17 (13.7%) 6 (7.3%) 
Not 
disclosed 
6 (4.8%) 7 (8.6%) 
Table 1:  Summary of the two groups 
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 Spontaneous conception ART 
Total screened 59 50 
Worst ROP found 
during screening, 
number (%) 
0 41 (69.5%) 33 (66%) 
1 5 (8.5%) 6 (12%) 
2 10 (16.9%) 8 (16%) 
3 3 (5.1%) 3 (6%) 
Any ROP 18 (30.5%) 17 (34%) 
Required treatment 5 (8.5%) 5 (10%) 
Table 2: Worst ROP seen during screening 
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 Odds Ratio 95% Confidence 
Intervals 
P value 
Birth weight (per 
gram) 
0.996 0.994 to 0.998 < 0.001 
ART 1.173 0.524 to 2.627 0.697 
Gestational age 0.571 0.458 to 0.71 < 0.001 
Table 3:  Logistic regression exploring associations between development of any 
ROP and baseline factors 
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 Years 
studied 
Country Number 
within 
screening 
criteria* 
Multiple 
birth 
babies 
within 
screening 
criteria; 
number 
(%) 
SC 
multiples 
screened;  
number 
(%) 
ART 
multiples 
screened;  
number (%) 
Current 
study 
2007-
2011 
UK 1272 205 
(16.1%) 
124 
(60.5%) 
 
81 
(39.5%) 
Blumenfeld 
et al 
1998[26] 
1992-
1995 
USA 840 149 (17%)   
Garg et al 
2010[27] 
1994-
2005 
Australia 10,068 2764 
(27.5%) 
  
Corchia et 
al 2014[28] 
2003-
2005 
Italy 2934 407 
(13.9%) 
288 
(70.8%) 
119 
(29.2%) 
Shah et al 
2011[19] 
2005-
2008 
Canada 1130 370 
(32.7%) 
233 (63%) 137 (37 
%) 
Picaud et 
al 2012[8] 
2003-
2007 
France 649** 240 
(37%)** 
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Table 4:  Comparison of data to international literature. *Total number of babies 
<32 weeks and/or <1501g regardless of screening criteria quoted in the study. 
**Included 37 triplets excluded from data analysis. 
 
 
